title: Diffuse mucosal damage in the large intestine associated with Irinotecan (CPT-11).
authors.affiliation: Department of Pathology, Broussais Hospital, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Duong Van Huyen
authors.forename: F
authors.initials: F
authors.lastname: Bloch
authors.forename: A
authors.initials: A
authors.lastname: Attar
authors.forename: D
authors.initials: D
authors.lastname: Levoir
authors.forename: C
authors.initials: C
authors.lastname: Kreft
authors.forename: T
authors.initials: T
authors.lastname: Molina
authors.forename: P
authors.initials: P
authors.lastname: Bruneval
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D003106:Colon / Q000473:pathology*; D003110:Colonic Neoplasms / Q000473:pathology; D017809:Fatal Outcome; D006801:Humans; D007413:Intestinal Mucosa / Q000473:pathology*; D000077146:Irinotecan; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D002166:Camptothecin